L-Arginine, ADMA, SDMA, creatinine, MDRD formula: Detour to renal function testing

Journal of Nephrology

Volumn 21, Issue 6, 2008, Pages 959-961

  Kielstein, Jan T ^a   Martens Lobenhoffer, Jens ^b   Vollmer, Stefan ^c   Bode Böger, Stefanie M ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c NONE

Author keywords

ADMA; Cockcroft Gault; L Arginine; MDRD formula; SDMA

Indexed keywords

ARGININE; CREATININE; DIGOXIN; N(G),N(G) DIMETHYLARGININE; BIOLOGICAL MARKER; DRUG DERIVATIVE; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE; NITRIC OXIDE SYNTHASE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE REPORT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; NEPHROSCLEROSIS; BLOOD; CHRONIC KIDNEY FAILURE; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; METABOLISM; MIDDLE AGED;

ARGININE; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DIETARY SUPPLEMENTS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NITRIC OXIDE SYNTHASE;

EID: 62749191290     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047.
2. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-2169.
3. Brosius FC III, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation. 2006;114:1083-1087.
4. Spoto B, Parlongo RM, Parlongo G, Sgro' E, Zoccali C. The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes. J Nephrol. 2007;20:554-559.
5. Meinitzer A, Seelhorst U, Wellnitz B, et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem. 2007;53:273-283.
6. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - a meta-analysis. Nephrol Dial Transplant. 2006;21:2446-2451.
7. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl 1):S1-S266.
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
9. Boger RH. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous? Curr Opin Clin Nutr Metab Care. 2008;11:55-61.
10. Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP. L-Arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation. 2007;116:188-195.
11. Levey AS, Stevens LA, Hostetter T. Automatic reporting of estimated glomerular filtration rate: just what the doctor ordered. Clin Chem. 2006;52:2188-2193.